Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 12 Observational 1

Sponsor

Cancer Type

Breast 33 Gastrointestinal 15 Thoracic 13 Other hematologic neoplasm 10 Lymphoid 9 Other 8 Genitourinary 6 Endocrine 2 Sarcoma 1 Gynecologic 1 Dermatologic 1 CNS 1

Conditions

Melanoma 467 Skin Neoplasms 144 Carcinoma, Basal Cell 94 Breast Neoplasms 78 Neoplasms 68 Lymphoma, T-Cell, Cutaneous 62 Lung Neoplasms 57 Carcinoma, Squamous Cell 40 Carcinoma, Non-Small-Cell Lung 40 Mycosis Fungoides 39 Uveal Melanoma 38 Sezary Syndrome 37 Lymphoma, Non-Hodgkin 35 Lymphoma 35 Keratosis, Actinic 35 Pancreatic Neoplasms 34 Sarcoma 33 Prostatic Neoplasms 33 Head and Neck Neoplasms 33 Colorectal Neoplasms 33 Leukemia, Lymphocytic, Chronic, B-Cell 31 Ovarian Neoplasms 30 Urinary Bladder Neoplasms 29 Multiple Myeloma 29 Precursor Cell Lymphoblastic Leukemia-Lymphoma 28 Lymphoma, B-Cell, Marginal Zone 28 Colonic Neoplasms 28 Lymphoma, Mantle-Cell 27 Lymphoma, Follicular 27 Leukemia 27

Interventions

pembrolizumab 1 Nivolumab 1 Ipilimumab 1 Immunotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Motor Activity × Dermatologic × Clear all

NCT06627595 2024-11-15

APiTOXMM

University Hospital, Montpellier

Melanoma, Motor Activity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡